Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

gadomer 17

Known as: gadomer-17 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Rationale and objectives: Gadomer-17 is a new magnetic resonance (MR) contrast medium presently in clinical development. It is a… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2004
Highly Cited
2004
To test magnetic resonance (MR) contrast media of different molecular weights (MWs) for their potential to characterize… Expand
Highly Cited
2004
Highly Cited
2004
To choose an efficacious renal functional MRI contrast agent to image early renal tubular damage. We synthesized and compared… Expand
Highly Cited
2004
Highly Cited
2004
A direct comparison of extracellular and intravascular contrast agents for the assessment of myocardial perfusion was carried out… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2002
2002
The uptake of Gadomer‐17, as probed by fast dynamic T1 measurements, was used to assess the vascular permeability surface‐area… Expand
2002
2002
Misselwitz B, Schmitt-Willich H, Michaelis M, et al. Interstitial magnetic resonance lymphography using a polymeric T1 contrast… Expand
2002
2002
PURPOSE To evaluate the ability of Gadomer-17 to depict perfusion defects in a closed-chest swine model of single-vessel coronary… Expand
2000
2000
RATIONALE AND OBJECTIVES This study compared gadopentetate dimeglumine (molecular weight, 0.5 kD), a standard contrast medium… Expand
Highly Cited
2000
Highly Cited
2000
A technique for the simultaneous measurement of three vascular parameters: blood flow (Fρ), blood volume (vb), and the capillary… Expand
Highly Cited
1998
Highly Cited
1998
RATIONALE AND OBJECTIVES Our purpose was to investigate a "blood pool" contrast agent for abdominal and thoracic MR angiography… Expand